查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362999

生物技术设备市场规模、份额和趋势分析报告：2023-2030 年按产品、最终用途和细分市场分類的趋势

Biotechnology Instruments Market Size, Share & Trends Analysis Report By Product (Cell Culture Instruments, Analytical Instruments), By End-use (Pharma & Biotech Companies, Academic & Research Institutes), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

生物技术设备市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球生物技术设备市场规模将达到1,166.8亿美元，2023年至2030年年复合成长率为3.94%。

生命科学研究技术的进步、对个体化药物和诊断测试的需求不断增加，以及针对癌症等疾病的药物和疫苗开发的增加，正在推动市场成长。政府不断配合措施建立门诊护理模式以缩短住院时间，以及家庭和医疗环境对 POC 设备的需求不断增长，以满足人口老化的需求，这推动了对 POC 诊断的需求。受以下要素影响：

此外，生物技术产业的扩张与多种要素有关，包括新的创新产品的引入、协议、收购、技术进步以及各种用途的采用增加。 2023 年 5 月，印度新兴企业NeoDx Biotech Labs 推出了七种基于即时 PCR 的试剂盒，用于诊断丙型肝炎、乙型肝炎和爱滋病毒感染疾病，这些试剂盒正在各医院和诊断中心使用。同样，2023 年 1 月，Bio-Rad 宣布推出其实时 PCR 系统 CFX Opus Deepwell Dx，并获得 FDA IVD 测试许可。因此，这些技术的推出预计将推动这段时期的市场成长。此外，该公司正在推出新产品，以促进更好、更先进的定序技术。

例如，2023年4月，Biomodal（原Cambridge Epigenetix）宣布推出其二重整学解决方案。预计这种新的多组学定序技术将突显从单一小样本中提取的遗传和表观遗传见解的协同潜力。此外，该解决方案是首批单碱基分辨率定序技术之一，允许从单一样本中同时阶段读出遗传和表观遗传细节。这扩展了该技术在与任何定序平台整合的工作流程中的应用。测序技术的进步预计将推动市场成长。

生物技术设备市场报告亮点

  • 从按产品来看，分析仪器领域在2022年占据市场主导地位，份额为61.92%。
  • 预计对先进药物开发、生物标记发现和药品品管的需求不断增长将推动该领域在预测期内的成长。
  • 依最终用途，製药和生技公司占最大市场占有率，2022年将达38.10%。
  • 这是由于癌症等各种疾病的药物治疗、疫苗开发以及用于疾病监测和检测的诊断工具的设计的增加。
  • 2022年，由于大公司的存在和强大的医疗基础设施，北美以43.95%的份额主导市场。

目录

第1章调查方法和范围

第2章执行摘要

第3章变数、趋势、范围

  • 市场体系预测
  • 市场趋势及展望
  • 市场动态
  • 市场抑制因素分析
  • 营商环境分析

第4章产品经营分析

  • 生物技术设备市场：产品变化分析
  • 分析设备
    • 聚合酶炼式反应
    • 光谱学
    • 显微镜检查
    • 色谱法
    • 流式细胞仪
    • 定序
    • 微阵列
    • 其他的
  • 细胞培养设备
    • 文化体系
    • 培养箱
    • 低温储存装置
    • 生物安全设备
    • 移液器设备
  • 细胞分离设备
    • 离心式
    • 过滤系统
    • 磁激活细胞分离系统
  • 免疫检测设备
  • 临床生化分析仪
  • 其他的

第5章最终用途业务分析

  • 生物技术设备市场：最终用途变化分析
  • 製药和生物技术公司
  • 医院/诊断实验室
  • 学术/研究机构
  • 其他的

第6章区域业务分析

  • 区域市场概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率分析
  • 公司简介/名单
    • Thermo Fisher Scientific, Inc.
    • Waters Corp.
    • Shimadzu Corp.
    • Danaher
    • Agilent Technologies, Inc.
    • Bruker Corp.
    • PerkinElmer, Inc.
    • Mettler Toledo
    • Zeiss Group
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • Eppendorf SE
    • F. Hoffmann-La Roche AG
    • Sartorius AG
    • Avantor, Inc.
Product Code: GVR-4-68039-625-9

Biotechnology Instruments Market Growth & Trends:

The global biotechnology instruments market size is expected to reach USD 116.68 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 3.94% from 2023 to 2030. The growing advancements in life science research technologies, growing demand for personalized medicines & diagnostics tests, and rising R&D for drug & vaccine developments for diseases, such as cancer, collectively propel the market growth. The demand for POC diagnostics is projected to be driven by factors, such as increasing government initiatives to establish outpatient care models for shortening hospital stays and the rising need for POC devices in home & healthcare settings to address the needs of the elderly population.

In addition, the expansion of the biotechnology industry can be linked to various factors including the introduction of new & innovative products, agreements, acquisitions, technological advancements, and growing adoption across different applications. In May 2023, NeoDx Biotech Labs, an Indian startup, launched 7 real-time PCR-based kits to diagnose infectious diseases, such as Hepatitis C, Hepatitis B, and HIV, at various hospitals and diagnostic centers. Similarly, in January 2023, Bio-Rad announced the launch of a real-time PCR system, CFX Opus Deepwell Dx, which is FDA-approved for IVD testing. Thus, these technological launches are projected to impel the market growth over the period. In addition, companies are launching new products to facilitate better and more advanced sequencing technology.

For instance, in April 2023, Biomodal, formerly known as Cambridge Epigenetix, announced the launch of the duet multiomics solution. This new multiomics sequencing technology is projected to highlight the synergistic potential of genetic and epigenetic insights extracted from a single low-volume sample. Moreover, the solution is one of the first single-base-resolution sequencing technologies, which enables simultaneous, phased reading of both genetic and epigenetic details from a single sample. This increases applications of the technology in unified workflows alongside any sequencing platforms. The increasing adoption of technological advancements in sequencing techniques is anticipated to impel market growth.

Biotechnology Instruments Market Report Highlights:

  • Based on product, the analytical instruments segment dominated the market in 2022 with a share of 61.92%
  • The growing demand for advanced drug development, biomarker discovery, and quality control across pharmaceuticals is anticipated to fuel the segment growth over the forecast period
  • Based on end-use, the pharmaceutical & biotechnological companies segment held the largest market share of 38.10% in 2022
  • This can be attributed to the increased number of drug therapies for various diseases, such as cancer, vaccine developments, and designing diagnostic tools for disease monitoring & detection
  • In 2022, North America dominated the market with a share of 43.95% owing to the presence of major players and robust healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends And Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing Demand For Analytical Instruments
    • 3.3.2. Growing Prevalence Of Target Diseases And Rising Geriatric Population
    • 3.3.3. Technological Advancements In Research-Use Instruments
  • 3.4. Market Restraint Analysis
    • 3.4.1. Higher Cost Of Devices
    • 3.4.2. Shortage Of Skilled Professionals
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Biotechnology Instruments Market: Product Movement Analysis
  • 4.2. Analytical Instruments
    • 4.2.1. Analytical Instruments Market, 2018 - 2030 (USD Million)
    • 4.2.2. Polymerase Chain Reaction
      • 4.2.2.1. Polymerase Chain Reaction, 2018 - 2030 (USD Million)
    • 4.2.3. Spectroscopy
      • 4.2.3.1. Spectroscopy, 2018 - 2030 (USD Million)
    • 4.2.4. Microscopy
      • 4.2.4.1. Microscopy, 2018 - 2030 (USD Million)
    • 4.2.5. Chromatography
      • 4.2.5.1. Chromatography, 2018 - 2030 (USD Million)
    • 4.2.6. Flow Cytometry
      • 4.2.6.1. Flow Cytometry, 2018 - 2030 (USD Million)
    • 4.2.7. Sequencing
      • 4.2.7.1. Sequencing, 2018 - 2030 (USD Million)
    • 4.2.8. Microarray
      • 4.2.8.1. Microarray, 2018 - 2030 (USD Million)
    • 4.2.9. Others
      • 4.2.9.1. Others, 2018 - 2030 (USD Million)
  • 4.3. Cell Culture Instruments
    • 4.3.1. Cell Culture Instruments Market, 2018 - 2030 (USD Million)
    • 4.3.2. Culture Systems
      • 4.3.2.1. Culture Systems Market, 2018 - 2030 (USD Million)
    • 4.3.3. Incubators
      • 4.3.3.1. Incubators Market, 2018 - 2030 (USD Million)
    • 4.3.4. Cryostorage Equipment
      • 4.3.4.1. Cryostorage Equipment Market, 2018 - 2030 (USD Million)
    • 4.3.5. Biosafety Equipment
      • 4.3.5.1. Biosafety Equipment Market, 2018 - 2030 (USD Million)
    • 4.3.6. Pipetting Instruments
      • 4.3.6.1. Pipetting Instruments Market, 2018 - 2030 (USD Million)
  • 4.4. Cell Separation Instruments
    • 4.4.1. Cell Separation Instruments Market, 2018 - 2030 (USD Million)
    • 4.4.2. Centrifuge
      • 4.4.2.1. Centrifuge Market, 2018 - 2030 (USD Million)
    • 4.4.3. Filtration Systems
      • 4.4.3.1. Filtration Systems Market, 2018 - 2030 (USD Million)
    • 4.4.4. Magnetic-activated Cell Separator Systems
      • 4.4.4.1. Magnetic-activated Cell Separator Systems Market, 2018 - 2030 (USD Million)
  • 4.5. Immunoassay Instruments
    • 4.5.1. Immunoassay Instruments Market, 2018 - 2030 (USD Million)
  • 4.6. Clinical Chemistry Analyzers
    • 4.6.1. Clinical Chemistry Analyzers Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End-use Business Analysis

  • 5.1. Biotechnology Instruments Market: End-use Movement Analysis
  • 5.2. Pharmaceutical & Biotechnology Companies
    • 5.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.3. Hospitals & Diagnostic Laboratories
    • 5.3.1. Hospitals & Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
  • 5.4. Academic & Research Institutes
    • 5.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.2.2.2. Key Country Dynamics
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. Target Disease Prevalence
      • 6.2.2.5. Regulatory Framework
    • 6.2.3. Canada
      • 6.2.3.1. Canada Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.2.3.2. Key Country Dynamics
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Target Disease Prevalence
      • 6.2.3.5. Regulatory Framework
  • 6.3. Europe
    • 6.3.1. Europe Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. Target Disease Prevalence
      • 6.3.2.5. Regulatory Framework
    • 6.3.3. Germany
      • 6.3.3.1. Germany Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Target Disease Prevalence
      • 6.3.3.5. Regulatory Framework
    • 6.3.4. Spain
      • 6.3.4.1. Spain Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.4.2. Key Country Dynamics
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Target Disease Prevalence
      • 6.3.4.5. Regulatory Framework
    • 6.3.5. France
      • 6.3.5.1. France Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.5.2. Key Country Dynamics
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Target Disease Prevalence
      • 6.3.5.5. Regulatory Framework
    • 6.3.6. Italy
      • 6.3.6.1. Italy Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.6.2. Key Country Dynamics
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Target Disease Prevalence
      • 6.3.6.5. Regulatory Framework
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.7.2. Key Country Dynamics
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Target Disease Prevalence
      • 6.3.7.5. Regulatory Framework
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.8.2. Key Country Dynamics
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Target Disease Prevalence
      • 6.3.8.5. Regulatory Framework
    • 6.3.9. Norway
      • 6.3.9.1. Norway Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.9.2. Key Country Dynamics
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Target Disease Prevalence
      • 6.3.9.5. Regulatory Framework
  • 6.4. Asia Pacific
    • 6.4.1. Asia-Pacific Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Target Disease Prevalence
      • 6.4.2.5. Regulatory Framework
    • 6.4.3. China
      • 6.4.3.1. China Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Target Disease Prevalence
      • 6.4.3.5. Regulatory Framework
    • 6.4.4. India
      • 6.4.4.1. India Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Target Disease Prevalence
      • 6.4.4.5. Regulatory Framework
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Target Disease Prevalence
      • 6.4.5.5. Regulatory Framework
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Target Disease Prevalence
      • 6.4.6.5. Regulatory Framework
    • 6.4.7. Australia
      • 6.4.7.1. Australia Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Target Disease Prevalence
      • 6.4.7.5. Regulatory Framework
  • 6.5. Latin America
    • 6.5.1. Latin America Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Target Disease Prevalence
      • 6.5.2.5. Regulatory Framework
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Target Disease Prevalence
      • 6.5.3.5. Regulatory Framework
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Target Disease Prevalence
      • 6.5.4.5. Regulatory Framework
  • 6.6. MEA
    • 6.6.1. MEA Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Target Disease Prevalence
      • 6.6.2.5. Regulatory Framework
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Target Disease Prevalence
      • 6.6.3.5. Regulatory Framework
    • 6.6.4. UAE
      • 6.6.4.1. UAE Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Target Disease Prevalence
      • 6.6.4.5. Regulatory Framework
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Target Disease Prevalence
      • 6.6.5.5. Regulatory Framework

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Thermo Fisher Scientific, Inc.
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Waters Corp.
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Shimadzu Corp.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Danaher
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Agilent Technologies, Inc.
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Bruker Corp.
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. PerkinElmer, Inc.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Mettler Toledo
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Zeiss Group
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Bio-Rad Laboratories, Inc.
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Illumina, Inc.
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. Eppendorf SE
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. F. Hoffmann-La Roche AG
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. Sartorius AG
      • 7.4.14.1. Company Overview
      • 7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives
    • 7.4.15. Avantor, Inc.
      • 7.4.15.1. Company Overview
      • 7.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Europe biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 12 Europe biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 UK biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 14 UK biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 16 Germany biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 France biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 18 France biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Italy biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 20 Italy biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Spain biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 22 Spain biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Denmark biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 24 Denmark biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Sweden biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 26 Sweden biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 China biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 33 China biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Japan biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 India biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 37 India biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 South Korea biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 39 South Korea biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Australia biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 43 Thailand biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Latin America biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 45 Latin America biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 46 Latin America biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Brazil biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 48 Brazil biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Mexico biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 50 Mexico biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Argentina biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 52 Argentina biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Africa biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Africa biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 UAE biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 61 UAE biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 63 Kuwait biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global biotechnology instruments market - Key market driver analysis
  • Fig. 7 Global biotechnology instruments market - Key market restraint analysis
  • Fig. 8 Global biotechnology instruments market - Porter's analysis
  • Fig. 9 Global biotechnology instruments market - PESTEL analysis
  • Fig. 10 Global biotechnology instruments market: Product outlook key takeaways
  • Fig. 11 Global biotechnology instruments market: Product movement analysis
  • Fig. 12 Analytical instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Polymerase chain reaction market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Spectroscopy market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Microscopy market estimates, 2018 - 2030 (USD Million)
  • Fig. 16 Chromatography market estimates, 2018 - 2030 (USD Million)
  • Fig. 17 Flow cytometry market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Sequencing market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Microarray market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Cell culture instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Culture systems market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Incubators market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Cryostorage equipment market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Biosafety equipment market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Pipetting instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 27 Cell separation instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 28 Centrifuge market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Filtration systems market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Magnetic - activated cell separator systems market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Immnuoassay instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Clinical chemistry analyzers market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 34 Global biotechnology instruments market: End - use outlook key takeaways
  • Fig. 35 Global biotechnology instruments market: End - use movement analysis
  • Fig. 36 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Hospitals & diagnostic laboratories market estimates, 2018 - 2030 (USD Million)
  • Fig. 38 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 40 Regional marketplace: Key takeaways
  • Fig. 41 Global biotechnology instruments market: Regional movement analysis
  • Fig. 42 North America biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 46 UK biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 48 France biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 53 Norway biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 56 China biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 57 India biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 65 MEA biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 68 UAE biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 70 Strategy framework